PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND C-ERBB-2 ONCOPROTEIN INBREAST-CARCINOMA WITH CORRELATIONS TO HISTOPATHOLOGICAL PARAMETERS AND PROGNOSIS

Citation
T. Haerslev et al., PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND C-ERBB-2 ONCOPROTEIN INBREAST-CARCINOMA WITH CORRELATIONS TO HISTOPATHOLOGICAL PARAMETERS AND PROGNOSIS, Oncology Reports, 2(1), 1995, pp. 99-105
Citations number
59
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
2
Issue
1
Year of publication
1995
Pages
99 - 105
Database
ISI
SICI code
1021-335X(1995)2:1<99:PCNA(A>2.0.ZU;2-E
Abstract
Overexpression of PCNA (more than 25% positive tumour cells) and posit ivity of c-erbB-2 oncoprotein were immunohistochemically demonstrated in 490 formalin-fixed and paraffin-embedded breast carcinomas. Overexp ression of PCNA and c-erbB-2 correlated with large tumour size, presen ce of lymph node metastases, high histological grade (poor differentia tion), and absence of steriod hormone receptors features indicating an aggressive phenotype. In univariate analysis overexpression of PCNA c orrelated with poor overall survival (p<0.05), whereas c-erbB-2 was of no prognostic significance. In multivariate analysis both PCNA and c- erbB-2 failed to be of independent prognostic significance. In order t o identify women with different prognosis an index termed immunoscore, based upon the results of the immunoreactivity of both PCNA and c-erb B-2 was constructed. The immunoscore was correlated with tumour size, lymph node status, histological grade, and steroid hormone receptor st atus. In univariate analysis of survival data the immunoscore was a pr ognostic parameter of poor overall survival. In multivariate analysis the classical histopathological parameters such as tumour size, histol ogical grade and progesterone receptor status turned out to be of inde pendent prognostic significance. The immunoscore was associated with p oor prognosis but did not reach independent statistical significance ( p=0.08). Further studies including a larger number of patients must be carried out in order to determine the prognostic significance of the immunoscore in multivariate analysis.